Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Thomas G. Gross, MD, PhD
Nationwide Children's Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
78 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Westmead Institute for Cancer Research at Westmead Hospital
Westmead, New South Wales, Australia
- Royal Children'S Hospital
Brisbane, Queensland, Australia
- Princess Margaret Hospital for Children
Perth, Western Australia, Australia
- University of Alberta Hospital
Edmonton, Alberta, Canada
- Children'S & Women'S Hospital of British Columbia
Vancouver, British Columbia, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Iwk Health Centre
Halifax, Nova Scotia, Canada
- Hospital for Sick Children
Toronto, Ontario, Canada
- Hopital Sainte Justine
Montreal, Quebec, Canada
- Montreal Children'S Hospital at Mcgill University Health Center
Montreal, Quebec, Canada
- Starship Children'S Health
Auckland, New Zealand
- Christchurch Hospital
Christchurch, New Zealand
- Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
Birmingham, Alabama, United States
- Phoenix Children'S Hospital
Phoenix, Arizona, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Southern California Permanente Medical Group
Downey, California, United States
- Loma Linda University Cancer Institute at Loma Linda University Medical Center
Loma Linda, California, United States
- Kaiser Permanente Medical Center - Oakland
Sacramento, California, United States
- Ucsf Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States
- Stanford Cancer Center
Stanford, California, United States
- Children'S Hospital Center for Cancer and Blood Disorders
Aurora, Colorado, United States
- Alfred I. Dupont Hospital for Children
Wilmington, Delaware, United States
- Lee Cancer Care of Lee Memorial Health System
Fort Myers, Florida, United States
- University of Florida Shands Cancer Center
Gainesville, Florida, United States
- Nemours Children'S Clinic
Jacksonville, Florida, United States
- University of Miami Sylvester Comprehensive Cancer Center - Miami
Miami, Florida, United States
- Sacred Heart Cancer Center at Sacred Heart Hospital
Pensacola, Florida, United States
- All Children'S Hospital
St. Petersburg, Florida, United States
- Winship Cancer Institute of Emory University
Atlanta, Georgia, United States
- Children'S Memorial Hospital - Chicago
Chicago, Illinois, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- University of Illinois Cancer Center
Chicago, Illinois, United States
- Simmons Cooper Cancer Institute
Springfield, Illinois, United States
- Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- Kosair Children'S Hospital
Louisville, Kentucky, United States
- Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana, United States
- C.S. Mott Children'S Hospital at University of Michigan Medical Center
Ann Arbor, Michigan, United States
- Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
- Butterworth Hospital at Spectrum Health
Grand Rapids, Michigan, United States
- Ccop - Kalamazoo
Kalamazoo, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2004
- Primary completion
- 1 Oct 2009
- Completion
- 31 Dec 2013
- Last update posted
- 6 Aug 2019
- Registered enrollment
- 55
- Registry id
- NCT00066469
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.